Lipitor is a drug used to lower cholesterol levels in the blood. The active ingredient in Lipitor is atorvastatin, which works by inhibiting an enzyme involved in the production of cholesterol in the liver [1].

According to a study published in the Journal of the Pancreas, there have been reports of pancreatitis associated with the use of atorvastatin [2]. The study states that while the incidence of pancreatitis is low, it is important to consider the possibility of this adverse effect when prescribing atorvastatin. The study also suggests that patients taking atorvastatin who develop abdominal pain or other symptoms of pancreatitis should be evaluated for this condition.

Another study published in the journal Digestive Diseases and Sciences also found a possible association between atorvastatin and pancreatitis [3]. The study analyzed data from a large healthcare database and found that patients taking atorvastatin had a higher risk of developing pancreatitis compared to those not taking the drug. However, the study did not establish a cause-and-effect relationship between atorvastatin and pancreatitis.

In conclusion, there is evidence to suggest a possible link between atorvastatin (the active ingredient in Lipitor) and pancreatitis. While the incidence of pancreatitis associated with atorvastatin is low, patients taking the drug who develop symptoms of pancreatitis should be evaluated for this condition. It is important for healthcare providers to consider the risks and benefits of atorvastatin when prescribing this medication [2][3].

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/LIPITOR
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133445/
[3] https://pubmed.ncbi.nlm.nih.gov/17147459/